Treatment Options for Pediatric Atopic Dermatitis

Systemic Therapy Recommendations

The American Academy of Dermatology recommends oral antihistamines as adjuvant therapy for reducing pruritus in pediatric atopic dermatitis patients, though evidence shows they work primarily through sedation rather than antipruritic effects 1
The Taiwan Academy of Pediatric Allergy, Asthma and Immunology suggests that sedating antihistamines may improve sleep quality in children with atopic dermatitis, but caution is warranted in school-age children due to potential negative effects on school performance 2, 3
The American Academy of Dermatology and the Taiwan Academy of Pediatric Allergy, Asthma and Immunology recommend dupilumab as the first-line biologic for severe to very severe atopic dermatitis refractory to topical treatment 1, 4
The Taiwan Academy of Pediatric Allergy, Asthma and Immunology suggests that immunomodulators including cyclosporine, azathioprine, and methotrexate may be used in children with very severe disease 1

The Taiwan Academy of Pediatric Allergy, Asthma and Immunology notes that special caution should be taken in patients with epilepsy when using antihistamines, with some agents contraindicated or associated with convulsions 1

The American Academy of Dermatology recommends optimizing topical therapy with appropriate-potency corticosteroids and liberal emollient use as the first-line approach for pediatric patients with significant pruritus from atopic dermatitis 4, 5

The American Academy of Dermatology notes that traditional oral immunosuppressants, such as cyclosporine, azathioprine, methotrexate, and mycophenolate mofetil, have significant toxicity concerns and require intensive monitoring, making dupilumab a preferred systemic option when injectable therapy is acceptable 6, 7, 8
The British Medical Journal recommends avoiding the use of systemic corticosteroids for maintenance therapy due to rebound flares upon discontinuation, and instead reserving them for short-term crisis management 8, 9